Knotless Implants As an Alternative for Capsular Closure in Primary Hip Arthroscopy: a Prospective, Multi-Center Study
Launched by AMERICAN HIP INSTITUTE · Jul 9, 2024
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to close the hip capsule after hip surgery, specifically for patients with a condition called Femoro Acetabular Impingement. The researchers want to find out if using a special device called the Arthrex LoopLocTM, which does not require knots, is better than traditional methods that use knotted sutures. The goal is to see if the LoopLocTM device can help reduce irritation and scar tissue around the hip after surgery, potentially leading to better recovery and less pain.
To participate in this study, you need to be under 60 years old and scheduled for a primary hip arthroscopy, where the surgeon will repair the hip capsule using the LoopLocTM device. Unfortunately, if you have had previous hip surgery or have certain specific conditions, you won’t be eligible for this trial. Participants in the study will be monitored to compare their recovery and outcomes with those who do not use the LoopLocTM device. This research aims to improve surgical techniques and outcomes for patients undergoing hip surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients undergoing a primary hip arthroscopy
- • Patients younger than 60 years old.
- • Patients who will receive capsular closure with the Arthrex LoopLocTM device following hip arthroscopy.
- Exclusion Criteria:
- • Patients that had previous hip surgery,
- • Patients that had a center edge angle (CEA) less than 25 degrees or greater than 40 degrees.
- • Patients that have a cartilage damage grade greater than or equal to 3.
About American Hip Institute
The American Hip Institute (AHI) is a leading research and clinical organization dedicated to advancing the field of hip preservation and treatment. With a focus on innovative surgical techniques and evidence-based practices, AHI conducts rigorous clinical trials aimed at improving patient outcomes and enhancing the understanding of hip disorders. The institute is committed to fostering collaboration among healthcare professionals, researchers, and patients, while prioritizing safety, efficacy, and the highest ethical standards in all its research initiatives. Through its cutting-edge studies, AHI seeks to contribute significantly to the advancement of orthopedic medicine and the quality of life for individuals suffering from hip-related conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Des Plaines, Illinois, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported